199 related articles for article (PubMed ID: 9613559)
1. Decreased myocardial 123I-MIBG uptake in Parkinson's disease.
Iwasa K; Nakajima K; Yoshikawa H; Tada A; Taki J; Takamori M
Acta Neurol Scand; 1998 May; 97(5):303-6. PubMed ID: 9613559
[TBL] [Abstract][Full Text] [Related]
2. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure.
Braune S; Reinhardt M; Bathmann J; Krause T; Lehmann M; Lücking CH
Acta Neurol Scand; 1998 May; 97(5):307-14. PubMed ID: 9613560
[TBL] [Abstract][Full Text] [Related]
3. [123 I-MIBG myocardial sympathetic innervation scintigraphy and Parkinson's disease. Preliminary results].
Jiménez-Hoyuela JM; Rebollo AC; Campos V; Rius F
Rev Esp Med Nucl; 2003; 22(4):229-37. PubMed ID: 12846947
[TBL] [Abstract][Full Text] [Related]
4. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
[TBL] [Abstract][Full Text] [Related]
5. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
6. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
[TBL] [Abstract][Full Text] [Related]
7.
Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
[TBL] [Abstract][Full Text] [Related]
8. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
[TBL] [Abstract][Full Text] [Related]
9. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
[TBL] [Abstract][Full Text] [Related]
10. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
[TBL] [Abstract][Full Text] [Related]
11. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
[TBL] [Abstract][Full Text] [Related]
12. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.
Taki J; Nakajima K; Hwang EH; Matsunari I; Komai K; Yoshita M; Sakajiri K; Tonami N
Eur J Nucl Med; 2000 May; 27(5):566-73. PubMed ID: 10853813
[TBL] [Abstract][Full Text] [Related]
13. [[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study].
Yamada A; Murakami T; Kang Y; Iikuni Y; Morimatsu A; Shirata A; Ito H; Ugawa Y; Yamane K
Rinsho Shinkeigaku; 2016 Jun; 56(6):400-6. PubMed ID: 27212677
[TBL] [Abstract][Full Text] [Related]
14. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease.
Yoshita M; Hayashi M; Hirai S
Nucl Med Commun; 1998 Feb; 19(2):137-42. PubMed ID: 9548197
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
[TBL] [Abstract][Full Text] [Related]
16. Reduced cardiac 123I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson's disease.
De Rosa A; Pappatà S; Pellegrino T; De Leva MF; Maddaluno G; Fiumara G; Carotenuto R; Petretta M; Filla A; De Michele G; Cuocolo A
Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1914-21. PubMed ID: 23929432
[TBL] [Abstract][Full Text] [Related]
17. Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus.
Mäntysaari M; Kuikka J; Mustonen J; Tahvanainen K; Vanninen E; Länsimies E; Uusitupa M
Clin Auton Res; 1996 Jun; 6(3):163-9. PubMed ID: 8832126
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of regional sympathetic dysfunction in acutely ischemic myocardium assessed by 123I-metaiodobenzylguanidine imaging: impairment of myocardial norepinephrine uptake or retention].
Ishida Y; Maeno M; Hirose Y; Takahashi N; Katabuchi T; Oka H; Hayashida K; Takamiya M; Nonogi H; Miyatake K
Kaku Igaku; 1995 Jul; 32(7):631-42. PubMed ID: 7674574
[TBL] [Abstract][Full Text] [Related]
19. Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.
Matsui H; Udaka F; Oda M; Tamura A; Kubori T; Nishinaka K; Kameyama M
Ann Nucl Med; 2005 May; 19(3):225-9. PubMed ID: 15981676
[TBL] [Abstract][Full Text] [Related]
20. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
